Treatment-refractory paraneoplastic opsoclonus-myoclonus syndrome in a patient with small-cell carcinoma of the lung

被引：1

作者：

Alkan, Ali ^{[1
]}

Cenikli, Utku ^{[2
]}

Uylas, Selcuk ^{[1
]}

Yilmaz, Mehmet ^{[3
]}

Cakir, Tumay ^{[4
]}

Cetinkaya, Halil ^{[5
]}

Kiran, Alkan ^{[1
]}

Tanriverdi, Ozgur ^{[1
]}

机构：

[1] Mugla Sitki Kocman Univ, Sch Med, Dept Internal Med, Med Oncol Unit, Mugla, Turkey

[2] Mugla Sitki Kocman Univ, Sch Med, Dept Neurol, Mugla, Turkey

[3] Mugla Sitki Kocman Univ, Sch Med, Dept Internal Med, Mugla, Turkey

[4] Mugla Sitki Kocman Univ, Sch Med, Dept Neurol, Intens Care Unit, Mugla, Turkey

[5] Mugla Sitki Kocman Univ, Sch Med, Dept Family Med, Mugla, Turkey

来源：

JOURNAL OF ONCOLOGY PHARMACY PRACTICE | 2020年 / 26卷 / 01期

关键词：

Opsoclonus-myoclonus syndrome; paraneoplastic syndrome; small-cell lung cancer; MANIFESTATION;

D O I：

10.1177/1078155219831366

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Opsoclonus-myoclonus syndrome is a rare disease and traditionally described as "dancing eyes, dancing feet syndrome." It is characterized by opsoclonus (oscillations of the eyes in either horizontally or vertically) and myoclonus (spontaneous jerky movements of the limbs and trunk). There are numerous etiological factors defined such as paraneoplastic, para-infectious, toxic-metabolic, and idiopathic causes. The experience of opsoclonus-myoclonus syndrome in adults is very limited. Here, we present a case of treatment-refractory paraneoplastic opsoclonus-myoclonus syndrome associated with small-cell carcinoma of the lung.

引用

页码：209 / 211

页数：3

共 16 条

[1] Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies
Armangue, Thais
Sabater, Lidia
Torres-Vega, Estefania
Martinez-Hernandez, Eugenia
Arino, Helena
Petit-Pedrol, Mar
Planaguma, Jesus
Bataller, Luis
Dalmau, Josep
Graus, Francesc
[J]. JAMA NEUROLOGY, 2016, 73 (04) : 417 - 424
[2] Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus
Bataller, L
Graus, F
Saiz, A
Vilchez, JJ
[J]. BRAIN, 2001, 124 : 437 - 443
[3] Opsoclonus-Myoclonus syndrome as a paraneoplastic manifestation of renal cell carcinoma - A case report and review of the literature
De Luca, S
Terrone, C
Crivellaro, S
De Zan, A
Polo, P
Vigliani, MC
Tizzani, A
[J]. UROLOGIA INTERNATIONALIS, 2002, 68 (03) : 206 - 208
[4] Paraneoplastic Opsoclonus-Myoclonus Syndrome Preceding a Mucosal Malignant Melanoma
Dresco, Flora
Aubin, Francois
Deveza, Elise
Revenco, Eugeniu
Tavernier, Laurent
Puzenat, Eve
[J]. ACTA DERMATO-VENEREOLOGICA, 2019, 99 (03) : 337 - 338
[5] Topiramate Effect in Opsoclonus-Myoclonus-Ataxia Syndrome
Fernandes, Thiago Dias
Bazan, Rodrigo
Betting, Luiz Eduardo
Gomes da Rocha, Fernando Coronetti
[J]. ARCHIVES OF NEUROLOGY, 2012, 69 (01) : 133 - 133
[6] Update on diagnosis, treatment, and prognosis in opsoclonus-myoclonus-ataxia syndrome
Gorman, Mark P.
[J]. CURRENT OPINION IN PEDIATRICS, 2010, 22 (06) : 745 - 750
[7] Laroumagne S, 2014, CASE REP MED, V2014, DOI 10.1155/2014/545490
[8] Leigh RJ, 2015, NEUROLOGY EYE MOVEME, P1109
[9] Paraneoplastic opsoclonus-myoclonus syndrome secondary to immature ovarian teratoma
Lou, Emil
Hensley, Martee L.
Lassman, Andrew B.
Aghajanian, Carol
[J]. GYNECOLOGIC ONCOLOGY, 2010, 117 (02) : 382 - 384
[10] Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004
Matthay, KK
Blaes, F
Hero, B
Plantaz, D
De Alarcon, P
Mitchell, WG
Pike, M
Pistoia, V
[J]. CANCER LETTERS, 2005, 228 (1-2) : 275 - 282

← 1 2 →